The role of natural antibodies in the activation of xenogenic endothelial cells.
Hyperacute rejection of organ xenografts is thought to be mediated by the reaction of naturally occurring antibodies and complement of the recipient with blood vessels in the donor organ. We have suggested previously that the pathogenesis of hyperacute rejection might involve the activation of endothelial cells in the graft. To evaluate the potential role of natural antibodies and complement in hyperacute xenograft rejection, sixteen human sera were tested for variation in the ability to activate porcine endothelial cells as manifested by the release of biosynthetically labeled heparan sulfate from the cells. It was then asked to which extent such variation might reflect differences in natural antibody titer and/or complement activity. The sera mediated release of 3.6-57% of endothelial cell-associated heparan sulfate. Heparan sulfate release correlated significantly with the titer, in the sera, of IgM antibodies that bound to cultured endothelial cells (P = 0.0008) or to a triad of glycoproteins believed to represent the major targets of natural antibodies in porcine to primate xenografts (P = 0.001); correlation was also observed with the total concentration of IgM (P = 0.0046). The release of heparan sulfate did not correlate with corresponding properties of serum IgG, with anti-swine hemagglutination or with isohemagglutination titers. Heparan sulfate release correlated with deposition on endothelial cells of iC3b (P = 0.0095), but not with serum complement activity. Our findings indicate that in the reaction between human serum and xenogeneic endothelial cells, it is the concentration of xenoreactive IgM and not differences in complement activity that limits the ensuing pathophysiologic events.
Platt
J L
JL
Department of Pediatrics, University of Minnesota, Minneapolis 55455.
Lindman
B J
BJ
Geller
R L
RL
Noreen
H J
HJ
Swanson
J L
JL
Dalmasso
A P
AP
Bach
F H
FH
D000328:Adult; D000818:Animals; D000906:Antibodies / Q000502:physiology*; D004730:Endothelium, Vascular / Q000166:cytology; D006023:Glycoproteins / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology*; D007074:Immunoglobulin G / Q000378:metabolism / Q000502:physiology; D007075:Immunoglobulin M / Q000378:metabolism / Q000502:physiology; D008875:Middle Aged; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
D000906:Antibodies; D006023:Glycoproteins; D007074:Immunoglobulin G; D007075:Immunoglobulin M